Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.

NCT01529086 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT01529086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01529086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
February 29, 2012
Enrollment
6,608 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer